MeSH tree: B01.043.075.380.611
Researchers have identified genetic changes in malaria parasites that may reduce the effectiveness of key antimalarial medicines, highlighting the need for continued surveillance.
Aug 10, 2026
0
7
Malaria is an ancient disease, dating back to 4,000–3,000 B.C., according to genetic evidence. Two hundred fifty million people are infected each year, and 610,000 cases are fatal. UIC researchers have developed a new antimalarial ...
Aug 4, 2026
0
11
The early-stage trial of a potential novel nonartemisinin malaria drug found it rapidly killed malaria parasites and was generally well tolerated in infected volunteers, showing it is a promising candidate for uncomplicated ...
Jul 15, 2026
0
8
Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps ...
Jul 11, 2026
0
13
The fever experienced by people with malaria exposes parasites to high temperatures within blood cells. This heat can lead to the accumulation of damaged proteins inside the parasite and trigger protective mechanisms against ...
Jul 10, 2026
0
6
In a remote South African village, Paulina Mhlongo sits in the yard as health workers in green protective gear move briskly through her home, soaking the walls with anti-mosquito insecticide.
Jun 8, 2026
0
6
A Portland State University-led research team has developed a novel chemical compound that shows promise for the treatment and prevention of malaria, one of the world's deadliest diseases. Malaria, a mosquito-borne infectious ...
May 13, 2026
0
9
Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI and global biopharmaceutical ...
Mar 19, 2026
0
20
New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of malaria. Published in ...
Feb 26, 2026
0
10
Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission. The new molecule acts during three phases of the disease cycle, eliminating the asexual form of ...
Feb 2, 2026
0
14
